Treatment of TASC C and D Aortoiliac Lesions — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment of TASC C and D Aortoiliac Lesions — Stella

Recruiting

Back to Peripheral Arterial Disease trials

Trial locations(1 site)

Serbia

Clinical Center of Serbia, Belgrade

Key details

Sponsor

Clinical Centre of Serbia

Collaborators

University of Belgrade, University of Trieste

Enrollment target

~900 participants

Started

May 2024

Primary completion

May 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 100 Years

Last updated August 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov